期刊文献+

大肠癌患者粪便p53基因检测及其临床意义 被引量:2

Detection of p53 gene in stool of patients with colorectal cancer and its clinical significance
下载PDF
导出
摘要 目的:研究大肠癌患者p5 3基因突变及蛋白表达之间关系,并探讨从粪便中检测p5 3基因突变在大肠癌早期诊断中的临床意义。方法:采用聚合酶链反应单链构象多态性分析(PCR SSCP)法,检测大肠癌患者癌组织和粪便标本中p5 3基因第5~8外显子突变情况;同时运用免疫组化法分析癌组织中p5 3表达情况。结果:34例大肠癌患者癌组织标本中,p5 3基因第5~8外显子突变及蛋白表达阳性率分别为5 2 .9%和5 5 .9% ,正常黏膜未见p5 3表达(P <0 .0 1)。p5 3表达与基因突变呈正相关关系(P <0 .0 5 )。p5 3表达阳性率与肿瘤组织大小有关,肿瘤≤5cm者阳性率高于>5cm者(P <0 .0 5 ) ,但与其它临床病理因素无关。12例癌组织中有p5 3基因突变的患者其粪便中基因突变阳性率为4 1.7% ,正常人未检测出突变。结论:p5 3基因突变是参与和影响p5 3表达和生物学功能的主要因素;大肠癌患者粪便中可检测出p5 3基因突变,粪便中p5 Objective:To study the relationship between p53 gene mutation and the protein expression,and their roles in the early diagnosis and clinical significances in colorectal cancer.Methods:Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP),the mutations in exon 58 of p53 gene were examined in the tumor tissues and stool of 34 patients and 10 healthy controls.At the same time,using immunohistochemistry(IHC)(S-Pmethods),p53 protein expression were examined in the tumor tissues and normal mucosa.Results:The mutation of exon 58 and protein expression of p53 gene in the tissues were found in 18 of 34(52.9%) cases and 19 of 34(55.9%) cases,respectively,no mutation and protein expression were positive in normal mucosa(P<(0.01)).Of 12 patients who were positive for p53 gene mutation in tumor tissue,5(41.7%) had evidence of alterations in the p53 gene within the stool.The positive rates of p53 protein expression was correlates with the mutation of exon 58.The expression of p53 protein was correlated with tumor size(P<0.05),but not correlates to other cliniopathological factors.Conclusions:Our data indicate that gene mutation of p53 is one of the main factors which participate and affect the protein expression.p53 gene mutation can be detected within the stools.Detection of p53 gene in stool may provide new ways for the early diagnosis and census of high risk population in colorectal cancers.
出处 《蚌埠医学院学报》 CAS 2005年第3期195-197,共3页 Journal of Bengbu Medical College
基金 安徽省教育厅自然科学研究资助项目 (2 0 0 0jL12 3 )
关键词 大肠肿瘤 基因 P53 聚合酶链反应 免疫组织化学 colorectal neoplasms genes p53 polymerase chain reaction immunohistochemistry
  • 相关文献

参考文献10

  • 1Scott N, Quirke P. Molecular biology of colorectal neoplasia[J ].Gut, 1993,34(3): 289 ~ 292.
  • 2宁向群,宫恩聪,吕愈敏,薛卫成,刘叔平,鄂文,廖松林.运用PCR-SSCP及免疫组化方法检测大肠肿瘤及粪便脱落细胞中P_53基因的突变[J].中华消化杂志,1996,16(2):115-117. 被引量:6
  • 3Eguchi S, Kohara N, Komuta K, et al. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer [J ].Cancer, 1996,77 (Suppl 8): 1 707~1 710.
  • 4Soussi T,Legros Y,Lubin R, et al. Multifactorial analysis of p53alteration in human cancer: A review. [J]. Int J Cancer, 1994,57(1):1~9.
  • 5Stephen CW,Helminen P, Lane DP. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: Insights into antibody peptide interactions[J ]. J Mol Biol, 1995,248( 1 ):58~78.
  • 6Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development[J]. N Engl J Med, 1998,319(9) :525~532.
  • 7Iyengar V,Albaugh GP, Lohani A, et al. Human stool as a source of viable colonic epithelial cells[J]. FASEB J, 1991, 5 (13):2 856~2 859.
  • 8Albangh GP, Iyengar V, Lohani A, et al. Isolation of exfoliated colonic epithelial cells, a novel non-invasive approach to the study of cellular markers[J]. Int J Cancer, 1992,52(3) :347~350.
  • 9Battifora H. p53 immunohistochemistry: A word of caution [ J ].Hum Pathol, 1994,25 (5): 435 ~ 437.
  • 10Wu JK, Ye Z, Barras BT. Sensitivity of single-strand conformation polymorphism(SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations[J]. Am J Hum Genet, 1993,52(6):1 273~1 275.

共引文献5

同被引文献54

  • 1郑向东,雷平光.胃癌、大肠癌组织中p27蛋白的表达及其意义[J].实用临床医药杂志,2004,8(6):8-9. 被引量:2
  • 2Vasen HF, Stomwrken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLHI mutation carvers: a study of hereditary nonpolyposis colorectal cancer families[J].J Clin Oncol,2001;19 (20):4074
  • 3Boun D.Three new colorectal cancer mutations found [J]. Lancet, 1999 ;353(9171 ) :2216
  • 4Srivastava S, Vemra M, Henson DE. Biomarkers for early detection of colon cancer [J].Clin Cancer Res,2001;7(5): 1118
  • 5Sikora K, Chan S,Evan G,et al.1C-myc oncogene expression in colorectal cancer[J]. Cancer,1987;59(7);1289
  • 6Sill H,Goldman JM Cross NC, et al.Homozygous deletions of p16 tumour suppressor gene are associated with lymphoid transformation ofchrorfic myeloid leukemia[J]. Blood, 1995; 85(8):2013
  • 7YamaoT, Matsumura Y, Shimada Y, et al. Abnormalexpression CD44v ariants in the exfoliatedcells in feces of patients with colorectal cancer. [J].Gastroenterology,1998; 144(6): 1196
  • 8Tanable KK, Ellis LM, SayaH.Expression of CD44R1, adhesion molecule in colorectal carcinoma and metastases [J]. Cancer, 1993; 341(8847):725.
  • 9Kim H, yang XL,Rosada C,et al. CD44 expression in colorectal adenomas is an early event occurring prior to K- ras and p53 gene mutation[J]. Arch Biochem Biophy,1994; 310(2):504
  • 10Matsumura Y. Hanbury D, Smrth J.et al. Non-invasive detection of mahgnancy by identification of unusual CD44 gene activity in expoliated cancer cells[J].Br Med J, 1994; 308:619

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部